Trials / Completed
CompletedNCT01930786
An Adult Spasticity Registry of OnabotulinumtoxinA Treatment
ASPIRE: Adult SPasticity International REgistry on BOTOX® Treatment
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 744 (actual)
- Sponsor
- Allergan · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
This is a registry study in adults with spasticity to determine onabotulinumtoxinA use in clinical practice. Treatment will be administered in accordance with physician standard practice. All treatment decisions lie with the physician.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | onabotulinumtoxinA | onabotulinumtoxinA administered according to physician standard of care. All treatment decisions lie with the physician. |
Timeline
- Start date
- 2013-10-16
- Primary completion
- 2017-10-09
- Completion
- 2017-10-09
- First posted
- 2013-08-29
- Last updated
- 2019-02-11
Locations
55 sites across 7 countries: United States, France, Germany, Italy, Spain, Taiwan, United Kingdom
Source: ClinicalTrials.gov record NCT01930786. Inclusion in this directory is not an endorsement.